News and Milestones
Latest News from the Foundation
The Foundation’s CEO visits ALS Clinic in Washington
Posted- April 14, 2025
The Foundation is pleased to announce that the CEO visited and toured the Washington ALS Clinic this past week.
The CEO briefed the Center’s doctors on the mission of the ALS Performance Research Foundation.
To speak with one of our science committee members, contact us via email at info@alsperformance.org
Foundation to attend Harvard Business Review Leaders Summit
Posted-April 15
Foundation’s team joins the HBR’s annual conference on leadership, the HBR Leadership Summit.
This full-day event features conversations with top global CEOs and leading management thinkers on pursuing both purpose and profits.
Foundation participates in commercial space and technology forum at SPARC Center
Posted April 16
The Foundation’s CEO attends space and technology program with the UW sparc center.
The science program covered the access to space and capabilities unlocked by cutting-edge technologies.
Speakers from industry discussed the new frontiers in space, driven by surging investment and increased activity from low-Earth orbit out to the moon and beyond.
The Foundation has expanded the Science and Medical Advisory Committee
The ALS Performance Research Foundation is excited to announce the additions of our science advisory committee. Our advisors are knowledgeable in multibaric technology and the physiological responses post treatment. Contact us to connect with our experts.
Programming: Did you know one of the multiple missions of our Foundation is to provide resources and community outreach to further the use of multi-baric technologies for ALS patients.
Current Users of Multi-baric systems: We can expand your knowledge of this technology with the latest information.
To speak with one of our science committee members, contact us via email at info@alsperformance.org or taran.sondhu@alsperformance.org
The Foundation announces additional studies
The Foundation conducted pilot studies with the use of multi-baric technology provided and collected surface EMG data immediately following subnormal (hypobaric) atmospheric changes from our ALS subjects. The analysis of surface EMG data demonstrates that this novel technology reduces neuronal activity. To prepare for clinical studies to help verify and validate this never seen before phenomenon the Foundation’s science team is currently conducting follow up neuromusclar studies with our enrolled ALS subjects.
To speak with one of our science committee members, contact us via email at info@alsperformance.org or taran.sondhu@alsperformance.org
The Foundation held meeting on April 7th with a major Midwest medical institution on Muscle Studies
The Foundation is pleased to announce the initiative to partner with muscle experts in neuromuscular medicine.
The Foundation team briefed the largest Midwest medical institution for neuromuscular medicine on surface EMG methods in ALS subjects. The discussions are a milestone in launching further studies and interest in measuring progression of neuromuscular disease.
To speak with one of our science committee members, contact us via email at info@alsperformance.org